Teriflunomide

Teriflunomide

SCHEMBL992140

C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1.[NaH]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DHODH

The experimentally established mechanism targets of Teriflunomide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DHODH known ✓ Q02127 9/20 0.97
EPHX2 P34913 1/20 0.50
TRPV1 Q8NER1 1/20 0.49
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
GAA P10253 1/20 0.46
CYP2C9 P11712 1/20 0.46
PKM P14618 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Teriflunomide SCHEMBL8466730 1.00 DHODH (0.97) DHODHEPHX2TRPV1NPC1RAB9A
Teriflunomide SCHEMBL22661 0.99 DHODH (1.00) DHODHEPHX2TRPV1NPC1RAB9A
Teriflunomide SCHEMBL2760666 0.99 DHODH (1.00) DHODHEPHX2TRPV1NPC1RAB9A
Teriflunomide SCHEMBL993119 0.99 DHODH (1.00) DHODHEPHX2TRPV1NPC1RAB9A
Teriflunomide SCHEMBL20214092 0.99 DHODH (1.00) DHODHEPHX2TRPV1NPC1RAB9A
Teriflunomide SCHEMBL991312 0.97 DHODH (0.97) DHODHEPHX2TRPV1NPC1RAB9A
SCHEMBL9079302 0.91 DHODH (0.85) DHODHEPHX2TRPV1
SCHEMBL8808801 0.91 DHODH (0.85) DHODHEPHX2TRPV1
SCHEMBL12312432 0.89 DHODH (0.82) DHODHALDH1A1MEN1CYP1A2CYP3A4
SCHEMBL8404982 0.87 DHODH (0.79) DHODHEPHX2TRPV1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120171490-A1 NOVEL POLYMORPHIC FORM OF TERIFLUNOMIDE SALTS ALEMBIC PHARMACEUTICALS LIMITED (IN) 2012-07-05 US claimed
EP-2451773-A2 NOVEL POLYMORPHIC FORM OF TERIFLUNOMIDE SALTS Alembic Pharmaceuticals Limited (IN) 2012-05-16 EP claimed
WO-2011004282-A2 NOVEL POLYMORPHIC FORM OF TERIFLUNOMIDE SALTS ALEMBIC LIMITED (IN) 2011-01-13 WO claimed
CN-101143834-B Polymorphism for N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide sodium salt and preparation method thereof XINKAI MEDICAL CHEMICAL INTERMEDIATE SHANGHAI CO LTD 2010-09-08 CN claimed
CN-101143834-A Polymorphism for N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide sodium salt and preparation method thereof XINKAI MEDICAL CHEMICAL INTERM (CN) 2008-03-19 CN claimed
US-20120171490-A1 NOVEL POLYMORPHIC FORM OF TERIFLUNOMIDE SALTS ALEMBIC PHARMACEUTICALS LIMITED (IN) 2012-07-05 US disclosed
US-20120171490-A1 NOVEL POLYMORPHIC FORM OF TERIFLUNOMIDE SALTS ALEMBIC PHARMACEUTICALS LIMITED (IN) 2012-07-05 US disclosed
EP-2451773-A2 NOVEL POLYMORPHIC FORM OF TERIFLUNOMIDE SALTS Alembic Pharmaceuticals Limited (IN) 2012-05-16 EP disclosed
EP-2451773-A2 NOVEL POLYMORPHIC FORM OF TERIFLUNOMIDE SALTS Alembic Pharmaceuticals Limited (IN) 2012-05-16 EP disclosed
WO-2011004282-A4 NOVEL POLYMORPHIC FORM OF TERIFLUNOMIDE SALTS ALEMBIC PHARMACEUTICALS LIMITED (IN) 2011-10-27 WO disclosed
WO-2011004282-A3 NOVEL POLYMORPHIC FORM OF TERIFLUNOMIDE SALTS ALEMBIC PHARMACEUTICALS LIMITED (IN) 2011-08-25 WO disclosed
WO-2011004282-A2 NOVEL POLYMORPHIC FORM OF TERIFLUNOMIDE SALTS ALEMBIC LIMITED (IN) 2011-01-13 WO disclosed
WO-2011004282-A2 NOVEL POLYMORPHIC FORM OF TERIFLUNOMIDE SALTS ALEMBIC LIMITED (IN) 2011-01-13 WO disclosed
CN-101143834-B Polymorphism for N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide sodium salt and preparation method thereof XINKAI MEDICAL CHEMICAL INTERMEDIATE SHANGHAI CO LTD 2010-09-08 CN disclosed
CN-101143834-B Polymorphism for N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide sodium salt and preparation method thereof XINKAI MEDICAL CHEMICAL INTERMEDIATE SHANGHAI CO LTD 2010-09-08 CN disclosed
CN-101143834-A Polymorphism for N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide sodium salt and preparation method thereof XINKAI MEDICAL CHEMICAL INTERM (CN) 2008-03-19 CN disclosed
CN-101143834-A Polymorphism for N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide sodium salt and preparation method thereof XINKAI MEDICAL CHEMICAL INTERM (CN) 2008-03-19 CN disclosed
US-5981536-A INHIBITING THE DEPHOSPHORYLATION OF COFILIN AND THUS HAVING MODULATING INFLUENCE ON APOPTOSIS HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-09 US disclosed
US-5856330-A MODULATION OF APOPTOSIS HOECHST AKTIENGESELLSCHAFT (DE) 1999-01-05 US disclosed